Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

2017-2022 Japan Mesenchymal Stem Cells Market Report (Status and Outlook)

  • LP 1465158
  • 118 Pages
  • August 2017
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Mesenchymal Stem Cells market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

In Japan market, the top players include

Lonza

Thermo Fisher

Bio-Techne

Miltenyi Biotec

PromoCell GmbH

Irvine Scientific

Axol Bioscience

STEMCELL Technologies

Biological Industries

Mesoblast

This report with sales, revenue and market share for each type, split by product types/category, covering

MSC-BM

MSC-UC

MSC-AT

Others

This report focuses on sales, market share and growth rate of Mesenchymal Stem Cells in each application, split by applications/end use industries, covers

Cell Differentiation and Gene Regulation

Gene Therapy and Transplantation

Cell-based Screening Assays

Others

Table of Contents

2017-2022 Japan Mesenchymal Stem Cells Market Report (Status and Outlook)

1 Mesenchymal Stem Cells Market Overview

1.1 Product Overview and Scope of Mesenchymal Stem Cells

1.2 Mesenchymal Stem Cells Market Segment by Types

1.2.1 Japan Mesenchymal Stem Cells Sales Present Situation and Outlook by Types (2012-2022)

1.2.2 Japan Mesenchymal Stem Cells Sales Market Share by Types in 2016

1.2.3 MSC-BM

1.2.4 MSC-UC

1.2.5 MSC-AT

Others

1.3 Japan Mesenchymal Stem Cells Market Segment by Applications/End Use Industries

1.3.1 Japan Mesenchymal Stem Cells Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)

1.3.2 Japan Mesenchymal Stem Cells Sales Market Share by Applications/End Industrials in 2016

1.3.3 Cell Differentiation and Gene Regulation

1.3.4 Gene Therapy and Transplantation

1.3.5 Cell-based Screening Assays

Others

1.4 Japan Mesenchymal Stem Cells Overview and Market Size (Value) (2012-2022)

1.4.1 Japan Market Mesenchymal Stem Cells Overview

1.4.2 Japan Mesenchymal Stem Cells Market Size (Value and Volume) Status and Forecast (2012-2022)

2 Japan Mesenchymal Stem Cells Sales, Revenue (Value) and Market Share by Players/Manufacturers

2.1 Japan Mesenchymal Stem Cells Sales and Market Share (2012-2017) by Vendors/Manufacturers

2.2 Japan Mesenchymal Stem Cells Revenue and Market Share by Vendors (2012-2017)

2.3 Japan Mesenchymal Stem Cells Average Price by Vendors in 2016

2.4 Japan Mesenchymal Stem Cells Manufacturing Base Distribution, Sales Area, Product Types by Vendors

2.5 Mesenchymal Stem Cells Market Competitive Situation and Trends

2.5.1 Mesenchymal Stem Cells Market Concentration Rate

2.5.2 Mesenchymal Stem Cells Market Share of Top 3 and Top 5 Vendors

2.5.3 Mergers & Acquisitions, Expansion

3 Japan Mesenchymal Stem Cells Sales, Revenue (Value) by Type and Application (2012-2017)

3.1 Japan Mesenchymal Stem Cells Sales, Revenue, Market Share and Price by Type (2012-2017)

3.1.1 Japan Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)

3.1.2 Japan Mesenchymal Stem Cells Revenue and Market Share by Type (2012-2017)

3.1.3 Japan Mesenchymal Stem Cells Price by Type (2012-2017)

3.2 Japan Mesenchymal Stem Cells Sales and Market Share by Application (2012-2017)

3.3 Japan Market Mesenchymal Stem Cells Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 Japan Mesenchymal Stem Cells Vendors/Manufacturers Profiles and Sales Data

4.1 Lonza

4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.1.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.1.2.1 Type 1

4.1.2.2 Type 2

4.1.3 Lonza Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.1.4 Main Business/Business Overview

4.2 Thermo Fisher

4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.2.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.2.2.1 Type 1

4.2.2.2 Type 2

4.2.3 Thermo Fisher Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.2.4 Main Business/Business Overview

4.3 Bio-Techne

4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.3.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.3.2.1 Type 1

4.3.2.2 Type 2

4.3.3 Bio-Techne Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.3.4 Main Business/Business Overview

4.4 Miltenyi Biotec

4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.4.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.4.2.1 Type 1

4.4.2.2 Type 2

4.4.3 Miltenyi Biotec Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.4.4 Main Business/Business Overview

4.5 PromoCell GmbH

4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.5.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.5.2.1 Type 1

4.5.2.2 Type 2

4.5.3 PromoCell GmbH Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.5.4 Main Business/Business Overview

4.6 Irvine Scientific

4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.6.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.6.2.1 Type 1

4.6.2.2 Type 2

4.6.3 Irvine Scientific Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.6.4 Main Business/Business Overview

4.7 Axol Bioscience

4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.7.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.7.2.1 Type 1

4.7.2.2 Type 2

4.7.3 Axol Bioscience Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.7.4 Main Business/Business Overview

4.8 STEMCELL Technologies

4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.8.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.8.2.1 Type 1

4.8.2.2 Type 2

4.8.3 STEMCELL Technologies Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.8.4 Main Business/Business Overview

4.9 Biological Industries

4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.9.2 Mesenchymal Stem Cells Product Types, Application and Specification

9.9.2.1 Type 1

9.9.2.2 Type 2

4.9.3 Biological Industries Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.9.4 Main Business/Business Overview

4.10 Mesoblast

4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

4.10.2 Mesenchymal Stem Cells Product Types, Application and Specification

4.10.2.1 Type 1

4.10.2.2 Type 2

4.10.3 Mesoblast Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

4.10.4 Main Business/Business Overview

5 Production Cost Analysis of Mesenchymal Stem Cells

5.1 Main Raw Materials of Mesenchymal Stem Cells

5.1.1 List of Mesenchymal Stem Cells Main Raw Materials

5.1.2 Mesenchymal Stem Cells Main Raw Materials Price Analysis

5.1.3 Mesenchymal Stem Cells Raw Materials Major Suppliers

5.1.4 Mesenchymal Stem Cells Main Raw Materials Market Concentration Rate

5.2 Production Cost Structure of Mesenchymal Stem Cells

5.2.1 Raw Materials

5.2.2 Labor Cost

5.2.3 Production Expenses

5.3 Mesenchymal Stem Cells Manufacturing Process/Method

6 Value Chain, Purchasing Strategy and Downstream Buyers

6.1 Mesenchymal Stem Cells Value Chain Analysis

6.2 Upstream Raw Materials Purchasing

6.3 Raw Materials Sources of Mesenchymal Stem Cells Major Vendors in 2016

6.4 Downstream Buyers

7 Marketing Strategy Analysis, Distributors/Traders

7.1 Sales Channel

7.1.1 Direct Sales

7.1.2 Indirect Sales

7.1.3 Sales Channel Development Trend

7.2 Product Market Positioning

7.2.1 Pricing Strategy

7.2.2 Brand Strategy

7.2.3 Target Client

7.3 Mesenchymal Stem Cells Distributors/Traders List in Japan

8 Market Influences Factors Analysis

8.1 Changes from the Related Industries

8.2 Substitutes Threat

8.3 Customer Preference Change

8.4 Economic/Political Environmental Change

8.5 Upstream and Downstream Fluctuation

9 Japan Mesenchymal Stem Cells Market Forecast (2017-2022)

9.1 Japan Mesenchymal Stem Cells Sales, Revenue and Price Forecast (2017-2022)

9.1.1 Japan Mesenchymal Stem Cells Sales and Growth Rate Forecast (2017-2022)

9.1.2 Japan Mesenchymal Stem Cells Revenue and Growth Rate Forecast (2017-2022)

9.1.3 Japan Mesenchymal Stem Cells Price Trend Forecast (2017-2022)

9.2 Japan Mesenchymal Stem Cells Sales Forecast by Type (2017-2022)

9.3 Japan Mesenchymal Stem Cells Sales Forecast by Application (2017-2022)

10 Research Findings and Conclusion

11 Appendix

11.1 Methodology

11.2 Data Source

List of Tables and Figures

Figure Picture of Mesenchymal Stem Cells

Table Product Specifications of Mesenchymal Stem Cells

Figure Japan Mesenchymal Stem Cells Sales (volume) for Each Type (2012-2022)

Figure Japan Mesenchymal Stem Cells Sales Market Share by Types in 2016

Table Types of Mesenchymal Stem Cells

Figure Product Picture of MSC-BM

Table Major Players of MSC-BM

Figure Product Picture of MSC-UC

Table Major Players of MSC-UC

Figure Product Picture of MSC-AT

Table Major Players of MSC-AT

Figure Product Picture of Others

Table Major Players of Others

Figure Japan Mesenchymal Stem Cells Sales Present Situation and Outlook by Applications (2012-2022)

Figure Japan Mesenchymal Stem Cells Sales Market Share by Applications/End Industrials in 2016

Table Applications of Mesenchymal Stem Cells

Figure Cell Differentiation and Gene Regulation Examples

Figure Gene Therapy and Transplantation Examples

Figure Cell-based Screening Assays Examples

Figure Others Examples

Figure Japan Mesenchymal Stem Cells Revenue (Million USD) Status and Forecast (2012-2022)

Figure Japan Mesenchymal Stem Cells Sales (Volume) Status and Forecast (2012-2022)

Table Japan Mesenchymal Stem Cells Sales by Vendors (2012-2017)

Table Japan Mesenchymal Stem Cells Sales Market Share (%) by Vendors (2012-2017)

Figure Japan Mesenchymal Stem Cells Sales Share by Vendors in 2016

Figure Japan Mesenchymal Stem Cells Sales Share by Vendors in 2017

Table Japan Mesenchymal Stem Cells Revenue (Million USD) by Vendors (2012-2017)

Table Japan Mesenchymal Stem Cells Revenue Market Share (%) by Vendors (2012-2017)

Figure Japan Mesenchymal Stem Cells Revenue Share by Vendors in 2016

Figure Japan Mesenchymal Stem Cells Revenue Share by Vendors in 2017

Figure Japan Mesenchymal Stem Cells Average Price by Vendors in 2016

Table Japan Mesenchymal Stem Cells Manufacturing Base Distribution and Sales Area by Vendors

Table Vendors Mesenchymal Stem Cells Product Types

Figure Mesenchymal Stem Cells Market Share of Top 3 Vendors

Figure Mesenchymal Stem Cells Market Share of Top 5 Vendors

Table Japan Mesenchymal Stem Cells Sales by Type (2012-2017)

Table Japan Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)

Figure Japan Mesenchymal Stem Cells Sales Market Share by Type 2016

Figure 2016 Japan Mesenchymal Stem Cells Sales Market Share by Type

Table Japan Mesenchymal Stem Cells Revenue (Million USD) by Type (2012-2017)

Table Japan Mesenchymal Stem Cells Revenue Market Share by Type (2012-2017)

Figure Japan Mesenchymal Stem Cells Revenue Market Share by Type 2016

Figure 2016 Japan Mesenchymal Stem Cells Revenue Market Share by Type

Table Japan Mesenchymal Stem Cells Price by Type (2012-2017)

Table Japan Mesenchymal Stem Cells Sales by Application (2012-2017)

Table Japan Mesenchymal Stem Cells Sales and Market Share by Application (2012-2017)

Figure Japan Mesenchymal Stem Cells Sales Market Share by Application (2012-2017)

Figure 2016 Japan Mesenchymal Stem Cells Sales Market Share by Application

Table Japan Market Mesenchymal Stem Cells Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

Table Lonza Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lonza Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Lonza Mesenchymal Stem Cells Market Share (2012-2017)

Table Thermo Fisher Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Thermo Fisher Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Thermo Fisher Mesenchymal Stem Cells Market Share (2012-2017)

Table Bio-Techne Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bio-Techne Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Bio-Techne Mesenchymal Stem Cells Market Share (2012-2017)

Table Miltenyi Biotec Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Miltenyi Biotec Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Miltenyi Biotec Mesenchymal Stem Cells Market Share (2012-2017)

Table PromoCell GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table PromoCell GmbH Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure PromoCell GmbH Mesenchymal Stem Cells Market Share (2012-2017)

Table Irvine Scientific Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Irvine Scientific Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Irvine Scientific Mesenchymal Stem Cells Market Share (2012-2017)

Table Axol Bioscience Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Axol Bioscience Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Axol Bioscience Mesenchymal Stem Cells Market Share (2012-2017)

Table STEMCELL Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table STEMCELL Technologies Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure STEMCELL Technologies Mesenchymal Stem Cells Market Share (2012-2017)

Table Biological Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biological Industries Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Biological Industries Mesenchymal Stem Cells Market Share (2012-2017)

Table Mesoblast Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mesoblast Mesenchymal Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Mesoblast Mesenchymal Stem Cells Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Mesenchymal Stem Cells Main Raw Materials Price Trend

Table Mesenchymal Stem Cells Raw Materials Major Suppliers List

Figure Production Cost Structure of Mesenchymal Stem Cells

Figure Mesenchymal Stem Cells Manufacturing Process/Method

Figure Mesenchymal Stem Cells Value Chain Analysis

Table Raw Materials Sources of Mesenchymal Stem Cells Major Vendors in 2016

Table Major Buyers of Mesenchymal Stem Cells

Table Mesenchymal Stem Cells Distributors/Traders List in Japan

Figure Japan Mesenchymal Stem Cells Sales and Growth Rate Forecast (2017-2022)

Figure Japan Mesenchymal Stem Cells Revenue and Growth Rate Forecast (2017-2022)

Figure Japan Mesenchymal Stem Cells Price Trend Forecast (2017-2022)

Table Japan Mesenchymal Stem Cells Sales Forecast by Type (2017-2022)

Figure Japan Mesenchymal Stem Cells Sales Market Share Forecast by Type (2017-2022)

Figure Japan Mesenchymal Stem Cells Sales Market Share Forecast by Type in 2022

Table Japan Mesenchymal Stem Cells Sales Forecast by Application (2017-2022)

Figure Japan Mesenchymal Stem Cells Sales Market Share Forecast by Application (2017-2022)

Figure Japan Mesenchymal Stem Cells Sales Market Share Forecast by Application in 2022

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
View Details
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370
View Details
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023

Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...

  • Publish Date: May 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research